secwatch.observer — SEC 8-K summary
======================================

Issuer:     NovoCure Ltd (NVCR)
CIK:        0001645113
Form:       8-K
Filed at:   2026-02-24T23:59:59+00:00
Accession:  0001645113-26-000013
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CMS rescinds retroactive revocation of Novocure's Medicare billing privileges
-----------------------------------------------------------------------------

- CMS revoked billing privileges retroactive to Dec 17, 2025; cited administrative re-validation issue, not substantive failure.
- On Feb 24, 2026, CMS rescinded revocation and reinstated privileges retroactively to Dec 17, 2025.
- Company continued patient services during revocation and expects no impact on revenue recognition.
- Revocation letter dated Jan 29, 2026; resolution achieved within one month.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645113/000164511326000013/0001645113-26-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645113/000164511326000013/nvcr-20260224.htm
  HTML page:      https://secwatch.observer/filing/0001645113-26-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer